Christopher Svendsen Associate Litigation Christopher represents technology and life sciences companies in a broad range of patent litigation matters.
Publications Delaware Reaffirms High Bar for Establishing a Material Adverse Effect December 23, 2019
Publications A Senior Executive Is Seriously Ill. When Should a Company Disclose the News? December 19, 2019
Experience Fenwick Represents Audentes Therapeutics in Pending $3B Acquisition by Astellas Pharma December 2, 2019
Media Coverage Fenwick’s Mike Dicke Talks SEC, Fundraising and Cryptocurrency Startups November 15, 2019
